{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:35:57Z","timestamp":1792643757368,"version":"4.5.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"am","delay-in-days":453,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.berh.2020.101529","type":"journal-article","created":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T17:34:52Z","timestamp":1592069692000},"page":"101529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Systemic autoinflammatory diseases: Clinical state of the art"],"prefix":"10.1016","volume":"34","author":[{"given":"Sophie","family":"Georgin-Lavialle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ducharme-Benard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Sarrabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Savey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Hentgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.berh.2020.101529_bib1","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDs): a Delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11926-018-0750-4","article-title":"An update on autoinflammatory diseases: inflammasomopathies","volume":"20","author":"Harapas","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.revmed.2018.01.004","article-title":"Clinical overview of auto-inflammatory diseases","volume":"39","author":"Georgin-Lavialle","year":"2018","journal-title":"Rev Med Interne"},{"issue":"8","key":"10.1016\/j.berh.2020.101529_bib4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/ni.3777","article-title":"The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation","volume":"18","author":"Manthiram","year":"2017","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.berh.2020.101529_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imj.14414","article-title":"Monogenic autoinflammatory disorders: beyond the periodic fever","volume":"50","author":"Moghaddas","year":"2020","journal-title":"Intern Med J"},{"issue":"10","key":"10.1016\/j.berh.2020.101529_bib6","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1136\/annrheumdis-2018-214472","article-title":"Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases","volume":"78","author":"Ter Haar","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2020.101529_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/BOR.0000000000000362","article-title":"Lessons from characterization and treatment of the autoinflammatory syndromes","volume":"29","author":"Aksentijevich","year":"2017","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00281-015-0496-2","article-title":"Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond","volume":"37","author":"Agyemang","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archdermatol.2011.3014","article-title":"DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name?","volume":"148","author":"Cowen","year":"2012","journal-title":"Arch Dermatol. mars"},{"issue":"10","key":"10.1016\/j.berh.2020.101529_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/intimm\/dxz024","article-title":"TNF receptor signalling in autoinflammatory diseases","volume":"31","author":"Jarosz-Griffiths","year":"2019","journal-title":"Int Immunol"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-018-0749-x","article-title":"An update on autoinflammatory diseases: relopathies","volume":"20","author":"Steiner","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2017-212403","article-title":"A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease","volume":"77","author":"Aeschlimann","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2020.101529_bib14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa1307361","article-title":"Early-onset stroke and vasculopathy associated with mutations in ADA2","volume":"370","author":"Zhou","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.berh.2020.101529_bib15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJMoa1307362","article-title":"Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy","volume":"370","author":"Navon Elkan","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/imr.12722","article-title":"Human adenosine deaminase 2 deficiency: a multi-faceted inborn error of immunity","volume":"287","author":"Moens","year":"2019","journal-title":"Immunol Rev"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11926-018-0748-y","article-title":"An update on autoinflammatory diseases: interferonopathies","volume":"20","author":"Davidson","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2020.101529_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.2011.06220.x","article-title":"Type I interferonopathies: a novel set of inborn errors of immunity","volume":"1238","author":"Crow","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2249.2011.04533.x","article-title":"Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1","volume":"167","author":"Goldbach-Mansky","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2020.101529_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2014.10.005","article-title":"Type I interferonopathies: mendelian type I interferon up-regulation","volume":"32","author":"Crow","year":"2015","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/imcb.12243","article-title":"Human inborn errors of the actin cytoskeleton affecting immunity: way beyond WAS and WIP","volume":"97","author":"Tangye","year":"2019","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12716","article-title":"Primary immunodeficiencies caused by mutations in actin regulatory proteins","volume":"287","author":"Janssen","year":"2019","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.berh.2020.101529_bib24","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.jaci.2019.02.003","article-title":"A\u00a0combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency","volume":"143","author":"Volpi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"22","key":"10.1016\/j.berh.2020.101529_bib25","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1182\/blood-2018-07-863431","article-title":"T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency","volume":"132","author":"Brigida","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.berh.2020.101529_bib26","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1084\/jem.20190147","article-title":"A\u00a0novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function","volume":"216","author":"Lam","year":"2019","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.jaci.2019.06.017","article-title":"Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1\u03b2 inhibition","volume":"144","author":"Gernez","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20161228","article-title":"Autoinflammatory periodic fever, immunodeficiency, and thrombocytopenia (PFIT) caused by mutation in actin-regulatory gene WDR1","volume":"214","author":"Standing","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"17","key":"10.1016\/j.berh.2020.101529_bib29","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2016-03-706028","article-title":"Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency","volume":"128","author":"Kuhns","year":"2016","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib30","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jaci.2018.04.023","article-title":"Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity","volume":"142","author":"Pfajfer","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.berh.2020.101529_bib31","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.berh.2017.12.001","article-title":"Periodic fever syndromes","volume":"31","author":"Lachmann","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.det.2016.07.005","article-title":"Dermatologic manifestations of monogenic autoinflammatory diseases","volume":"35","author":"Shwin","year":"2017","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jclinpath-2016-203810","article-title":"Autoinflammatory diseases: update on classification diagnosis and management","volume":"70","author":"Pathak","year":"2017","journal-title":"J\u00a0Clin Pathol"},{"issue":"1 Pt 2","key":"10.1016\/j.berh.2020.101529_bib35","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.lpm.2018.12.003","article-title":"Autoinflammatory diseases: state of the art","volume":"48","author":"Georgin-Lavialle","year":"2019","journal-title":"Presse Med"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib36","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/annrheumdis-2014-206580","article-title":"Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers","volume":"74","author":"Federici","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/archinte.1958.00260190052007","article-title":"Familial mediterranean fever","volume":"102","author":"Heller","year":"1958","journal-title":"AMA Arch Intern Med"},{"issue":"18","key":"10.1016\/j.berh.2020.101529_bib38","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial mediterranean fever. A double-blind trial","volume":"291","author":"Dinarello","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A\u00a0candidate gene for familial Mediterranean fever","volume":"17","year":"1997","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium","volume":"90","year":"1997","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.ejhg.5200658","article-title":"The spectrum of familial mediterranean fever (FMF) mutations","volume":"9","author":"Touitou","year":"2001","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.berh.2020.101529_bib42","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/rheumatology\/kep296","article-title":"The spectrum of MEFV clinical presentations--is it familial Mediterranean fever only?","volume":"48","author":"Ben-Chetrit","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.revmed.2018.02.005","article-title":"Familial mediterranean fever","volume":"39","author":"Georgin-Lavialle","year":"2018","journal-title":"Rev Med Interne"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib44","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","article-title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever","volume":"74","author":"Giancane","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/humu.20080","article-title":"Infevers: an evolving mutation database for auto-inflammatory syndromes","volume":"24","author":"Touitou","year":"2004","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.berh.2020.101529_bib46","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/art.37935","article-title":"Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children?","volume":"65","author":"Hentgen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2020.101529_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10067-016-3421-8","article-title":"Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants","volume":"36","author":"S\u00f6nmez","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-9-3","article-title":"Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study","volume":"9","author":"Ben-Zvi","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"332","key":"10.1016\/j.berh.2020.101529_bib49","doi-asserted-by":"crossref","first-page":"332ra45","DOI":"10.1126\/scitranslmed.aaf1471","article-title":"Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation","volume":"8","author":"Masters","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.berh.2020.101529_bib50","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1136\/annrheumdis-2017-211473","article-title":"A novel pyrin-associated autoinflammation with neutrophilic dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever","volume":"76","author":"Moghaddas","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2020.101529_bib51","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00281-015-0491-7","article-title":"CAPS--pathogenesis, presentation and treatment of an autoinflammatory disease","volume":"37","author":"Kuemmerle-Deschner","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib54","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1086\/302874","article-title":"Identification of a locus on chromosome 1q44 for familial cold urticaria","volume":"66","author":"Hoffman","year":"2000","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib55","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.revmed.2017.09.002","article-title":"Cryopyrin-associated periodic syndromes","volume":"39","author":"Quartier","year":"2018","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.berh.2020.101529_bib56","first-page":"235","article-title":"Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome","volume":"31","author":"Muckle","year":"1962","journal-title":"Q\u00a0J Med"},{"issue":"6","key":"10.1016\/j.berh.2020.101529_bib57","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/10408363.2018.1488805","article-title":"Mosaicism in autoinflammatory diseases: cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review","volume":"55","author":"Labrousse","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"14","key":"10.1016\/j.berh.2020.101529_bib58","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jaci.2019.11.035","article-title":"NLRP3-associated autoinflammatory diseases: phenotypic and molecular characteristics of germline versus somatic mutations","volume":"145","author":"Louvrier","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.berh.2020.101529_bib59","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib60","first-page":"163","article-title":"Nosologic aspects of systemic forms of very-early-onset juvenile arthritis. Apropos of 17 cases","volume":"60","author":"Prieur","year":"1984","journal-title":"Sem Hop"},{"issue":"2","key":"10.1016\/j.berh.2020.101529_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.berh.2020.101529_bib62","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00005792-199405000-00002","article-title":"Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group","volume":"73","author":"Drenth","year":"1994","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.berh.2020.101529_bib64","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MD.0b013e318190cfb7","article-title":"Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome","volume":"87","author":"van der Hilst","year":"2008","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib65","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.berh.2020.101529_bib66","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the eurofever registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib67","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","article-title":"AA amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6 Suppl 115","key":"10.1016\/j.berh.2020.101529_bib68","first-page":"110","article-title":"Serum immunoglobulin D levels in patients with Beh\u00e7et\u2019s disease according to different clinical manifestations","volume":"36","author":"Lucherini","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2020.101529_bib69","first-page":"33","article-title":"Diagnostic value of urinary mevalonic acid excretion in patients with a clinical suspicion of mevalonate kinase deficiency (MKD)","volume":"27","author":"Jeyaratnam","year":"2016","journal-title":"JIMD Rep"},{"issue":"8","key":"10.1016\/j.berh.2020.101529_bib70","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.berh.2020.101529_bib71","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/ni.3487","article-title":"Control of the innate immune response by the mevalonate pathway","volume":"17","author":"Akula","year":"2016","journal-title":"Nat Immunol"},{"issue":"20","key":"10.1016\/j.berh.2020.101529_bib72","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3899\/jrheum.170684","article-title":"Efficacy of continuous interleukin 1 blockade in mevalonate kinase deficiency: a multicenter retrospective study in 13 adult patients and literature review","volume":"45","author":"Deshayes","year":"2018","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib74","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/BOR.0000000000000314","article-title":"Alarming consequences - autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1","volume":"28","author":"Holzinger","year":"2016","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib75","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jaci.2015.04.016","article-title":"Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases","volume":"136","author":"Holzinger","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib76","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semarthrit.2015.02.012","article-title":"Novel PSTPIP1 gene mutation in a patient with pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome","volume":"45","author":"Lindwall","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib77","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.revmed.2018.02.003","article-title":"NLRC4 associated autoinflammatory diseases: a systematic review of the current literature","volume":"39","author":"Rodrigues","year":"2018","journal-title":"Rev Med Interne"},{"issue":"10","key":"10.1016\/j.berh.2020.101529_bib78","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.berh.2020.101529_bib79","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/ACI.0000000000000396","article-title":"NLRC4 inflammasomopathies","volume":"17","author":"Romberg","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib80","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1073\/pnas.0708616105","article-title":"Mutations in NALP12 cause hereditary periodic fever syndromes","volume":"105","author":"J\u00e9ru","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.berh.2020.101529_bib82","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"73","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.berh.2020.101529_bib84","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fped.2018.00282","article-title":"Vasculopathy, immunodeficiency, and bone marrow failure: the intriguing syndrome caused by deficiency of adenosine deaminase 2","volume":"6","author":"Lee","year":"2018","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3899\/jrheum.181384","article-title":"A\u00a0monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2","volume":"47","author":"\u00d6zen","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2020.101529_bib86","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/art.39699","article-title":"Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases","volume":"68","author":"Nanthapisal","year":"2016","journal-title":"Arthrit Rheumatol (Hoboken, NJ)"},{"issue":"Suppl 1","key":"10.1016\/j.berh.2020.101529_bib87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/1756-185X.13283","article-title":"Diagnosis and management of ADA2 deficient polyarteritis nodosa","volume":"22","author":"Human","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.berh.2020.101529_bib88","article-title":"Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2)","volume":"13","author":"Lee","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.berh.2020.101529_bib89","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMc1801927","article-title":"Treatment strategies for deficiency of adenosine deaminase 2","volume":"380","author":"Ombrello","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib90","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-0948","article-title":"Renal amyloidosis in deficiency of adenosine deaminase 2: successful experience with canakinumab","volume":"142","author":"Kisla Ekinci","year":"2018","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.berh.2020.101529_bib91","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3899\/jrheum.150024","article-title":"A\u00a0case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations","volume":"42","author":"Batu","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2020.101529_bib92","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fimmu.2017.00399","article-title":"NF-\u03baB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases","volume":"8","author":"Aksentijevich","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2020.101529_bib93","article-title":"New data in causes of autoinflammatory diseases","author":"Kone-Paut","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"6404","key":"10.1016\/j.berh.2020.101529_bib94","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.aar2641","article-title":"Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation","volume":"361","author":"Cuchet-Louren\u03b7o","year":"2018","journal-title":"Science"},{"issue":"7788","key":"10.1016\/j.berh.2020.101529_bib95","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-019-1828-5","article-title":"Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease","volume":"577","author":"Lalaoui","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib96","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1073\/pnas.1813582116","article-title":"Human RIPK1 deficiency causes combined immunodeficiency and inflammatory bowel diseases","volume":"116","author":"Li","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7788","key":"10.1016\/j.berh.2020.101529_bib97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41586-019-1830-y","article-title":"A\u00a0dominant autoinflammatory disease caused by non-cleavable variants of RIPK1","volume":"577","author":"Tao","year":"2020","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","article-title":"Copa syndrome: a novel autosomal dominant immune dysregulatory disease","volume":"36","author":"Vece","year":"2016","journal-title":"J\u00a0Clin Immunol"},{"issue":"594","key":"10.1016\/j.berh.2020.101529_bib100","first-page":"372","article-title":"Systemic juvenile onset idiopathic arthritis and adult onset still disease","volume":"14","author":"Theodoropoulou","year":"2018","journal-title":"Rev Med Suisse"},{"issue":"8","key":"10.1016\/j.berh.2020.101529_bib101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11926-017-0673-5","article-title":"Schnitzler syndrome: a review","volume":"19","author":"Gusdorf","year":"2017","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3476(87)80285-8","article-title":"Syndrome of periodic fever, pharyngitis, and aphthous stomatitis","volume":"110","author":"Marshall","year":"1987","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.berh.2020.101529_bib103","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/rheumatology\/ket460","article-title":"International periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome cohort: description of distinct phenotypes in 301 patients","volume":"53","author":"Hofer","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2020.101529_bib104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-3476(99)70321-5","article-title":"Periodic fever syndrome in children","volume":"135","author":"Thomas","year":"1999","journal-title":"J\u00a0Pediatr"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib105","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1542\/peds.2009-0088","article-title":"Differentiating PFAPA syndrome from monogenic periodic fevers","volume":"124","author":"Gattorno","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.berh.2020.101529_bib106","article-title":"Do we need the PFAPA syndrome in adults with non-monogenic periodic fevers?","author":"Fayand","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib107","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41431-018-0130-6","article-title":"A\u00a0decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience","volume":"26","author":"Rama","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.berh.2020.101529_bib108","article-title":"Positive impact of expert reference center validation on performance of next-generation sequencing for genetic diagnosis of autoinflammatory diseases","volume":"8","author":"Boursier","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib109","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.semarthrit.2013.04.011","article-title":"Evidence-based recommendations for the practical management of familial mediterranean fever","volume":"43","author":"Hentgen","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2020.101529_bib110","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2020.101529_bib111","first-page":"616","article-title":"Colchicine-induced lactose malabsorption in patients with familial Mediterranean fever","volume":"31","author":"Fradkin","year":"1995","journal-title":"Isr J Med Sci"},{"issue":"5","key":"10.1016\/j.berh.2020.101529_bib112","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib113","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3109\/15563650.2011.589844","article-title":"Unrecognized fatalities related to colchicine in hospitalized patients","volume":"49","author":"Mullins","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"10.1016\/j.berh.2020.101529_bib114","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/431592","article-title":"Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study","volume":"41","author":"Hung","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.berh.2020.101529_bib115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/rheumatology\/kez270","article-title":"Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers","volume":"59","author":"Papa","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib116","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1172\/JCI121526","article-title":"JAK inhibitors in autoinflammation","volume":"128","author":"Hoffman","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.berh.2020.101529_bib117","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1172\/JCI98814","article-title":"JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies","volume":"128","author":"Sanchez","year":"2018","journal-title":"J\u00a0Clin Invest"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694220300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:20:59Z","timestamp":1761499259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694220300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1521694220300462"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2020.101529","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic autoinflammatory diseases: Clinical state of the art","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2020.101529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101529"}}